Shaily is one of the few global manufacturers of insulin pens and has expanded its portfolio ... 50% capacity expansion in January, increasing production from 1,000 tonnes per day to 1,500 tonnes.

"We are currently engaging with market participants," a spokesperson for South Africa's Competition Commission told Reuters, declining to provide details. USAID cuts put tuberculosis response in peril ...

Close-up Weight Loss Medication on Conveyor Line during Production Process at Modern Pharmaceutical Factory. Insulin Injection Pens Manufacturing. Medicinal Drug Production Plant. Close-up Weight Loss ...

When administered once per week, Ozempic enhances insulin production in response to high blood sugar levels, leading to better glucose management. It helps slow digestion, reduce the release of ...

South Africa's competition watchdog is investigating drugmakers Novo Nordisk and Sanofi over possible anti-competitive ...

Dublin, March 06, 2025 (GLOBE NEWSWIRE) -- The "Insulin Pens Market Size by Segments, Share, Regulatory, Reimbursement and Forecast to 2036" report has been added to ResearchAndMarkets.com's offering.

Once fully operational, the facility is expected to produce approximately 15 million insulin pens annually, covering the needs of 500,000 patients across Saudi Arabia. This production milestone will ...

South Africa's competition watchdog launches a crucial investigation into pharmaceutical giants Novo Nordisk and Sanofi over ...

In November last year, Novo Nordisk told Reuters that it was phasing out production of human insulin pens, as it spends billions to increase manufacturing of its popular obesity and diabetes ...

The plant will make three types of insulin, which Civica has pledged to sell for $30 a vial and $55 for a box of five pens.

Merilog is available in a 3 mL prefilled pen and a 10 mL vial, joining two long-acting insulin biosimilars approved by the FDA in 2021. Merilog, a rapid-acting human insulin analog, is the first ...